Related Experiment Video
Updated: Feb 3, 2026

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
Published on: October 11, 2022
Not the same thing: metastatic PTCs have a different background than ATCs.
Dario de Biase1, Federica Torricelli2, Moira Ragazzi3
1Department of Pharmacy and Biotechnology (Dipartimento di Farmacia e Biotecnologie) - Molecular Diagnostic Unit, Azienda USL di Bologna, University of Bologna, Bologna, Italy.
Anaplastic thyroid cancer (ATC) and distant metastatic papillary thyroid cancer (DM-PTC) share TERT promoter mutations, indicating a common driver of aggressiveness. Increased mutations negatively impact survival in these aggressive thyroid cancers.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Anaplastic thyroid cancer (ATC) is highly aggressive, while differentiated papillary thyroid cancer (PTC) rarely metastasizes.
- The genetic similarities between aggressive ATC and distantly metastatic PTC (DM-PTC) are not well-defined.
- Understanding the genetic underpinnings of thyroid cancer aggressiveness is crucial for targeted therapies.
Purpose of the Study:
- To investigate the genetic background of ATC and DM-PTC using next-generation sequencing (NGS).
- To compare the genetic profiles of aggressive thyroid cancers (ATC/DM-PTC) with non-aggressive controls (ctrl-PTC).
- To identify genetic alterations associated with thyroid cancer aggressiveness and patient survival.
Main Methods:
- Analyzed a panel of 128 amplicons across 21 thyroid cancer-related genes in 151 thyroid cancer samples.
- Utilized next-generation sequencing (NGS) for comprehensive genetic profiling.
- Performed correlation analysis to assess the impact of mutations on patient overall survival.
Main Results:
- The ATC/DM-PTC group exhibited a higher overall mutational load compared to ctrl-PTCs.
- TERT promoter mutations were significantly overrepresented in both ATC (61.1%) and DM-PTC (48.2%) compared to ctrl-PTCs (7.6%).
- In ATC, TERT promoter mutations frequently co-occurred with TP53 mutations; this was not observed in DM-PTC. MED12 mutations showed no significant association with aggressiveness.
Conclusions:
- TERT promoter mutations are a key driver of aggressiveness in both ATC and DM-PTC, suggesting a shared genetic pathway.
- Distinct genetic profiles exist between ATC and DM-PTC, despite the shared TERT promoter mutation prevalence.
- An increasing number of mutations negatively correlates with overall survival in aggressive thyroid cancer subtypes.
Related Concept Videos
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Cross-Sectional Research
Groupthink
Relationship Formation
Robbers Cave

